(lp0
S'Why Dynavax Technologies Corporation Stock Is Skyrocketing Today Motley Fool - Mar 1, 2017 Shares of the clinical-stage biotech Dynavax Technologies Corporation  gained more than 28% in pre-market trading today -- soaring more than 40% at the open -- after the company announced that the FDA has accepted its response to the&nbsp;...Dynavax Technologies Corporation  Looks Like A PDUFA Winner - Insider FinancialDid Market Over-React to FDA News on Dynavax Technologies Corporation (NASDAQ ... - StockNewsUnion'
p1
aS"Dynavax Technologies Corporation  Shares Jump on NDA Acceptance Smarter Analyst - Feb 28, 2017 Dynavax Technologies Corporation  investors cheer the news that the FDA has accepted for review Dynavax's responses to the Complete Response Letter  issued by the FDA in November 2016 for the Biologics License Application for&nbsp;...Dynavax Announces FDA Acceptance for Review of Its Complete Response to ... - Marketwired FDA to review Dynavax's responses to HEPLISAV-B CRL, action date August 10 ... - Seeking Alpha"
p2
aS"Dynavax: Important Catalyst For SD101 Seeking Alpha - Apr 5, 2017 After the devastating failure of Heplisav-B to win an FDA approval for reasons I can only term perplexing, Dynavax'  fate now hinges on the success of the previously unheard-of oncology molecule SD-101."
p3
aS'Dynavax: A Wee Glimmer Of Hope Seeking Alpha - Mar 3, 2017 Dynavax stalwarts had been throwing in so many towels that there were few left to throw. So great was the despair that the teeniest bit of good news rocketed the stock upwards.'
p4
aS"Dynavax Technologies Corporation  Presents Clinical Data from SD-101 at ... Smarter Analyst - Mar 6, 2017 Dynavax Technologies Corporation  announced the presentation of findings in patients with metastatic melanoma in the dose escalation phase of an ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist,&nbsp;...UPDATE: Dynavax shares reverse premarket losses to open flat - MarketWatch"
p5
aS'Dynavax In 2017: Hero Or Zero? Seeking Alpha - Jan 18, 2017 The deeper I have gone into the Dynavax story, the more I have come to believe that its own recurring failures are the author of its current unhappy situation.'
p6
aS"Dynavax: What's Next For The Company? Seeking Alpha - Nov 15, 2016 Dynavax common stock plunged today after receiving a complete response letter from the FDA regarding its approval application for HEPLISAV-B vaccine.Stock Update : Here's Why Dynavax Technologies Corporation Shares ... - Smarter AnalystWhy Dynavax Technologies Shares Are Crashing 63% Today - Motley Fool"
p7
aS'Stock Update : Dynavax Technologies Corporation Reports 4Q and ... Smarter Analyst - Mar 13, 2017 Dynavax Technologies Corporation  reported financial results for the fourth quarter and year ended December 31, 2016.'
p8
aS"Dynavax Technologies Corporation  Plunges 5.98% on April 04 Equities.com - Apr 4, 2017 Dynavax Technologies Corporation  had a rough trading day for Tuesday April 04 as shares tumbled 5.98%, or a loss of $-0.35 per share, to close at $5.50.Here's What Happened To Dynavax Technologies Corporation  and ... - Market Exclusive"
p9
aS'Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline Seeking Alpha - Jan 17, 2017 Dynavax management seems to be positioning it as an immune-oncology company for near future. We think investors are under-appreciating the future commercial potential of this immune-oncology pipeline .'
p10
a.